Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches

SIMPLE SUMMARY: Oesophageal adenocarcinoma (OAC) is a leading cause of cancer mortality in the United Kingdom with a 5-year survival rate of approximately 15%. Major contributors to poor outcome are late diagnosis and chemotherapy resistance, and while targeted therapies have benefitted certain canc...

Descripción completa

Detalles Bibliográficos
Autores principales: McCabe, Niamh H., Stevenson, Leanne, Scanlon, Enya, Douglas, Rosalie, Kennedy, Susanna, Keminer, Oliver, Windshügel, Björn, Zisterer, Daniela, Kennedy, Richard D., Blayney, Jaine K., Turkington, Richard C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367554/
https://www.ncbi.nlm.nih.gov/pubmed/35954391
http://dx.doi.org/10.3390/cancers14153726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367554/
https://www.ncbi.nlm.nih.gov/pubmed/35954391
http://dx.doi.org/10.3390/cancers14153726

Ejemplares similares